
Many tumors take on added and more complex chromosome abnormalities as they progress.
In chronic myelogenous leukemia (CML), this is a factor of certain secondary cell changes and the course of the disease in later stages.
Research is ongoing to see if there is a correlation with specific types of lymphoma. Data are also being compared to results of genetics research.
© Copyright 2000-2009 Cedars-Sinai Health System.
All
rights reserved.
Privacy Policy
Terms and Conditions
